Form D PNI0826 a Series of CGF2
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 4 UroGen Pharma Ltd. For: Oct 08 Filed by: Degnan Chris
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 424B2 MORGAN STANLEY
Preliminary Pricing Supplement No. 19,433
Registration Statement Nos. 333-293641; 333-293641-01
Dated October 9, 2026
Filed pursuant to Rule 424(b)(2)
Morgan Stanley Finance LLC
Structured Investments
Callable Contingent Income Securities due October 18, 2029
Based on the Worst Performing of the... (continue reading...)
Form 3 Bradbury Capital Inc. For: Oct 06 Filed by: SOON CHONG SENG
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form D Rapid Brain Labs Co
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
More SEC Filings
View Older Stories-
Form F-1 vVARDIS Holding AG
-
Form SCHEDULE 13G RIVERNORTH OPPORTUNITIES Filed by: Equitable Holdings, Inc.
-
Form 424B2 CITIGROUP INC
-
Form D/A Egerton Long-Short Fund
-
Form D Andira Medicine Inc.
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 8-K Columbia Seligman Premiu For: Oct 09
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 6-K BTQ Technologies Corp. For: Oct 09
-
Form 424B2 MORGAN STANLEY
-
Form D/A Egerton Long-Short Fund
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form 4 5E Advanced Materials, For: Oct 08 Filed by: Weibel Paul Wesley III
-
Form N-CSR Two Roads Shared Trust For: Jul 31
-
Form 424B2 BofA Finance LLC
-
Form 487 FT 13250
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form 8-K Origin Bancorp, Inc. For: Oct 09
-
Form D/A Egerton Capital Equity
-
Form 4 GIBRALTAR INDUSTRIES, For: Oct 09 Filed by: Shah Manish H
-
Form D/A Blue Owl Real Estate
-
Form D EBP Opportunity, L.P.
-
Form 487 FT 13254
-
Form 424B2 CITIGROUP INC
-
Form 487 FT 13252
-
Form 487 FT 13253
-
Form 487 FT 13251
-
Form 487 FT 13255
-
Form D/A Egerton Capital Partners
-
Form D Evergen Equity 40, LP
-
Form 4/A SCOTTS MIRACLE-GRO CO For: Oct 02 Filed by: Scheiwer Mark J
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form 487 FT 13249
-
Form D Athanor Compute, Inc.
-
Form 424B2 MORGAN STANLEY
-
Form 13F-HR Arbor Wealth Advisors For: Sep 30
-
Form D/A Egerton Investment Partn
-
Form SCHEDULE 13D/A Karbon-X Corp. Filed by: Morsevo Trade, Inc.
-
Form 424B2 BofA Finance LLC
-
Form 424B2 MORGAN STANLEY
-
Form 497 ETF Opportunities Trust
-
Form 13F-HR ARMSTRONG ADVISORY GROUP For: Sep 30
-
Form 497 ETF Opportunities Trust
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form D/A Two Sigma Active Extensi
-
Form N-8F/A Polen Credit Opportuniti
-
Form D/A Takahe Global Markets
-
Form 424B2 BARCLAYS BANK PLC
-
Form N-CEN Tidal Trust II For: Jul 31
-
Form 13F-HR Insight Wealth Strategie For: Sep 30
